PYY and type 2 diabetes mellitus: In conclusion, our data indicate that GPR119 agonism with GSK263 causes substantial changes in circulating total PYY levels, but it did not improve glycemic control in subjects with type 2 diabetes when dosed alone or with metformin or sitagliptin.